Gene-expression-based biomarker predicts long-term risk of breast cancer recurrence
A comparison of three methods of predicting the risk of recurrence in women treated for estrogen-receptor (ER)-positive breast cancer finds that only the breast cancer index (BCI) – a biomarker based on the expression levels ...
Sep 11, 2013
0
0